Carlee Moser

3.2k total citations
50 papers, 1.0k citations indexed

About

Carlee Moser is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Carlee Moser has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Emergency Medicine and 12 papers in Virology. Recurrent topics in Carlee Moser's work include HIV-related health complications and treatments (22 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (9 papers). Carlee Moser is often cited by papers focused on HIV-related health complications and treatments (22 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (9 papers). Carlee Moser collaborates with scholars based in United States, Germany and Austria. Carlee Moser's co-authors include Judith S. Currier, Grace A. McComsey, Todd T. Brown, James H. Stein, Theodoros Kelesidis, Michael P. Dubé, Heather J. Ribaudo, Patrick T. Ellinor, Emelia J. Benjamin and Lisa Sullivan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carlee Moser

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlee Moser United States 16 497 402 319 216 138 50 1.0k
Allison C. Ross United States 11 512 1.0× 209 0.5× 199 0.6× 96 0.4× 100 0.7× 18 678
Suman Srinivasa United States 15 514 1.0× 217 0.5× 231 0.7× 147 0.7× 143 1.0× 43 802
Andreas Ronit Denmark 16 252 0.5× 277 0.7× 124 0.4× 85 0.4× 328 2.4× 51 837
Douglas Kitch United States 21 1.2k 2.4× 994 2.5× 678 2.1× 37 0.2× 288 2.1× 38 1.8k
Heather A. Algren United States 6 925 1.9× 776 1.9× 657 2.1× 20 0.1× 100 0.7× 7 1.1k
María del Mar Gutiérrez Spain 15 291 0.6× 265 0.7× 227 0.7× 15 0.1× 119 0.9× 36 582
Elena Meneghini Italy 10 181 0.4× 113 0.3× 115 0.4× 31 0.1× 52 0.4× 18 423
Barbara Menzaghi Italy 16 270 0.5× 316 0.8× 180 0.6× 19 0.1× 115 0.8× 46 534
Jen-Tse Cheng United States 14 249 0.5× 321 0.8× 113 0.4× 28 0.1× 152 1.1× 28 1.0k
Benvenuto Grisorio Italy 19 360 0.7× 295 0.7× 188 0.6× 277 1.3× 527 3.8× 27 1.2k

Countries citing papers authored by Carlee Moser

Since Specialization
Citations

This map shows the geographic impact of Carlee Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlee Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlee Moser more than expected).

Fields of papers citing papers by Carlee Moser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlee Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlee Moser. The network helps show where Carlee Moser may publish in the future.

Co-authorship network of co-authors of Carlee Moser

This figure shows the co-authorship network connecting the top 25 collaborators of Carlee Moser. A scholar is included among the top collaborators of Carlee Moser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlee Moser. Carlee Moser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lindsell, Christopher J., Matthew S. Shotwell, Kevin J. Anstrom, et al.. (2024). The statistical design and analysis of pandemic platform trials: Implications for the future. Journal of Clinical and Translational Science. 8(1). e155–e155.
3.
4.
Choudhary, Manish C., Amy Heaps, Rinki Deo, et al.. (2024). Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response. SHILAP Revista de lepidopterología. 9(2). 79–93. 1 indexed citations
5.
Premeaux, Thomas A., Carlee Moser, Martin Hoenigl, et al.. (2024). Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIV. iScience. 27(6). 109945–109945. 1 indexed citations
6.
Jilg, Nikolaus, Mark J Giganti, Kara W Chew, et al.. (2024). SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19. Clinical Infectious Diseases. 79(4). 920–927.
7.
Currier, Judith S., Carlee Moser, Joseph J. Eron, et al.. (2023). ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients. The Journal of Infectious Diseases. 228(Supplement_2). S77–S82. 5 indexed citations
8.
Chew, Kara W, Carlee Moser, David A. Wohl, et al.. (2023). Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial. The Journal of Infectious Diseases. 228(Supplement_2). S83–S91. 2 indexed citations
9.
Moser, Carlee, Xin Sun, Priscilla Y. Hsue, et al.. (2023). Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy. The Journal of Infectious Diseases. 228(1). 64–69. 3 indexed citations
10.
Ramirez, Sydney I., Alba Grifoni, Daniela Weiskopf, et al.. (2022). Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses. JCI Insight. 7(24). 5 indexed citations
11.
Moser, Carlee, Eric S. Daar, David A. Wohl, et al.. (2021). Symptom outcome measures for outpatient COVID-19 phase 3 treatment trials. 29(1). 140–141.
12.
Moser, Carlee, Meredith S. Duncan, Edzard Schwedhelm, et al.. (2021). Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. PLoS ONE. 16(9). e0254577–e0254577. 1 indexed citations
13.
Hoenigl, Martin, Carlee Moser, Nicholas Funderburg, et al.. (2018). Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy–mediated Viral Suppression. Clinical Infectious Diseases. 69(4). 676–686. 41 indexed citations
14.
Kelesidis, Theodoros, Carlee Moser, James H. Stein, et al.. (2016). Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. The Journal of Infectious Diseases. 214(5). 748–752. 9 indexed citations
15.
Moser, Carlee, Mayetri Gupta, Brett N. Archer, & Laura F. White. (2015). The Impact of Prior Information on Estimates of Disease Transmissibility Using Bayesian Tools. PLoS ONE. 10(3). e0118762–e0118762. 8 indexed citations
16.
Kelesidis, Theodoros, Thuy Tien T. Tran, James H. Stein, et al.. (2015). Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clinical Infectious Diseases. 61(4). 651–660. 98 indexed citations
17.
Brown, Todd T., Carlee Moser, Judith S. Currier, et al.. (2015). Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. The Journal of Infectious Diseases. 212(8). 1241–1249. 88 indexed citations
18.
Schnabel, Renate B., Michiel Rienstra, Lisa Sullivan, et al.. (2013). Risk Assessment for Incident Heart Failure in Individuals With Atrial Fibrillation. European Journal of Heart Failure. 15(8). 843–849. 86 indexed citations
19.
Moser, Carlee & Mayetri Gupta. (2012). A Generalized Hidden Markov Model for Determining Sequence-based Predictors of Nucleosome Positioning. Statistical Applications in Genetics and Molecular Biology. 11(2).
20.
Magnani, Jared W., Carlee Moser, Joanne M. Murabito, et al.. (2012). Age of natural menopause and atrial fibrillation: The Framingham Heart Study. American Heart Journal. 163(4). 729–734. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allison C. Ross Breakdown of academic impact, for papers by Suman Srinivasa Breakdown of academic impact, for papers by Andreas Ronit Breakdown of academic impact, for papers by Douglas Kitch Breakdown of academic impact, for papers by Heather A. Algren Breakdown of academic impact, for papers by María del Mar Gutiérrez Breakdown of academic impact, for papers by Elena Meneghini Breakdown of academic impact, for papers by Barbara Menzaghi Breakdown of academic impact, for papers by Jen-Tse Cheng Breakdown of academic impact, for papers by Benvenuto Grisorio
Rankless by CCL
2026